Core Laboratories Inc. $CLB Shares Sold by US Bancorp DE

US Bancorp DE lessened its stake in Core Laboratories Inc. (NYSE:CLB) by 31.7% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 6,873 shares of the oil and gas company’s stock after selling 3,186 shares during the period. US Bancorp DE’s holdings in Core Laboratories were worth $103,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the stock. Natixis Advisors LLC acquired a new position in Core Laboratories during the 1st quarter valued at about $257,000. XTX Topco Ltd bought a new stake in Core Laboratories during the first quarter worth approximately $155,000. Mackenzie Financial Corp raised its holdings in Core Laboratories by 5.0% during the first quarter. Mackenzie Financial Corp now owns 24,556 shares of the oil and gas company’s stock worth $368,000 after purchasing an additional 1,170 shares in the last quarter. Ridgewood Investments LLC raised its holdings in Core Laboratories by 2.7% during the first quarter. Ridgewood Investments LLC now owns 33,486 shares of the oil and gas company’s stock worth $502,000 after purchasing an additional 874 shares in the last quarter. Finally, Integrated Investment Consultants LLC raised its holdings in Core Laboratories by 58.0% during the first quarter. Integrated Investment Consultants LLC now owns 16,047 shares of the oil and gas company’s stock worth $241,000 after purchasing an additional 5,893 shares in the last quarter. Institutional investors and hedge funds own 97.81% of the company’s stock.

Core Laboratories Stock Performance

NYSE:CLB opened at $10.44 on Monday. Core Laboratories Inc. has a twelve month low of $9.72 and a twelve month high of $21.83. The company has a current ratio of 2.27, a quick ratio of 1.70 and a debt-to-equity ratio of 0.47. The company has a 50-day moving average of $11.72 and a 200-day moving average of $12.96. The firm has a market cap of $489.57 million, a price-to-earnings ratio of 16.84, a price-to-earnings-growth ratio of 3.15 and a beta of 1.41.

Core Laboratories (NYSE:CLB) last posted its quarterly earnings data on Wednesday, July 23rd. The oil and gas company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.18 by $0.01. Core Laboratories had a net margin of 5.73% and a return on equity of 14.15%. The company had revenue of $130.16 million during the quarter, compared to analyst estimates of $129.19 million. During the same quarter last year, the firm posted $0.22 EPS. The business’s revenue for the quarter was down .3% on a year-over-year basis. Analysts forecast that Core Laboratories Inc. will post 0.96 earnings per share for the current fiscal year.

Core Laboratories Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, August 25th. Stockholders of record on Monday, August 4th will be given a dividend of $0.01 per share. The ex-dividend date is Monday, August 4th. This represents a $0.04 annualized dividend and a dividend yield of 0.4%. Core Laboratories’s dividend payout ratio (DPR) is 6.45%.

Analyst Ratings Changes

CLB has been the topic of several recent analyst reports. Stifel Nicolaus dropped their target price on Core Laboratories from $13.00 to $12.00 and set a “hold” rating on the stock in a report on Wednesday, July 16th. Wall Street Zen raised Core Laboratories from a “sell” rating to a “hold” rating in a report on Saturday, July 26th. Finally, Citigroup dropped their target price on Core Laboratories from $16.00 to $13.00 and set a “neutral” rating on the stock in a report on Tuesday, May 13th.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.